Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PharmEng International has announced that its wholly owned subsidiary, Keata Pharma has received a drug establishment license for its manufacturing facility located in Sydney, Nova Scotia.
Subscribe to our email newsletter
The establishment license is for the manufacturing, testing and packaging of the following drug dosage forms; capsules, powders, solutions and tablets.
The establishment license was issued after a good manufacturing practices inspection was conducted under the authority of the Food and Drugs Act to verify compliance with the applicable regulations.
The 46,400 sq ft Sydney facility includes pilot laboratories for formulation development, rooms with various capabilities such as high shear mixing, container blending and equipment for modified release technology. The facility provides formulation development and testing services to manufacture and package products in solid and liquid dosage forms.